API manufacturing

Broad Capabilities. Boutique Services. Every program deserves a partner, not just a provider. We built Bio Duro to be exactly the right size: broad enough to support your science at every stage, agile enough to move when you need to move, and focused enough to treat your program like the priority it is. Explore Our Capabilities All Company News October 1, 2026 June 6, 2026 May 28, 2026 April 28, 2026 April 23, 2026 March 12, 2026 March 3, 2026 February 10, 2026 January 27, 2026 November 18, 2025 August 20, 2025 July 30, 2025 June 10, 2025 May 8, 2025 April 7, 2025 March 25, 2025 March 5, 2025 January 20, 2025 January 9, 2025 January 6, 2025 October 24, 2024 October 1, 2024 September 16, 2024 All Company News Deliver solutions using enabling technologies like AI enabled molecular design, high throughput screening, DNA-coded library, parallel synthesis. Explore Chemistry Most visited.

AI-assisted molecular designanalytical chemistrybioanalysiscomputational chemistryDMPKDNA-encoded library screeningdrug product manufacturingformulation developmenthigh-throughput screeningin vitro assaysin vivo modelsmedicinal chemistryparallel synthesispeptide chemistryprocess R&Dscale upsynthetic chemistrytoxicology

Chemical and Pharmaceutical Solutions, Inc., founded in 2002, focuses on the production of Active Pharmaceutical Ingredients (APIs), their intermediates, and the services required to produce these products in a highly regulated marketplace. The company has assembled a global network to support products from early clinical trials through launch or generic status, helping establish supply lines, solve technical and regulatory problems, and prepare for commercialization.

Catalytic TransformationsChromatography / Simulated Moving Bedcommercialization supportContinuous ChemistryHigh Containment Purifications / Scavenging Technologiesregulatory support

Drug Discovery Alliances provides a pharmaceutical R&D platform backed by an integrated team of CMC consultants and a global network of preferred suppliers, driving programs from discovery phase to commercialization. Founded in 2001 by Deborah Minor, Ph.D., the company supports biotech and pharmaceutical companies with drug discovery, drug development, CMC consulting, and regulatory support.

analytical method developmentantibody manufacturingcatalysis screeningCMC consultingcrystallizationformulation developmentGMP auditingGMP manufacturingIND application preparationmedicinal chemistrypreclinical developmentprocess researchregulatory supportsolid form screening

EUROAPI is a world leader in active pharmaceutical ingredients (APIs) with approximately 200 products in its portfolio, offering a large span of technologies while developing innovative molecules through its Contract Development and Manufacturing Organization (CDMO). The company aims to secure the core of the healthcare value chain, providing high-quality and sustainable API solutions to pharmaceutical and biotech clients across more than 80 countries, with around 3,100 employees and 5 production sites in Europe.

CDMOmicrobial fermentationmicronizationparticle engineeringsmall molecules synthesis